Potential Diagnostic Markers of Diabetic Retinopathy: Serum LncRNA MIAT, HOTTIP, SNHG16
Bo Li,Yan-Jun Du,Feng Xu,Hong-Bing Li,Xu Yang
DOI: https://doi.org/10.2147/dmso.s470755
2024-11-16
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Bo Li, 1, &ast Yan-Jun Du, 2, &ast Feng Xu, 3 Hong-Bing Li, 4 Xu Yang 1 1 Ophthalmology Center, Suining Central Hospital, Suining, People's Republic of China; 2 Department of Cardiovascular Medicine, Suining Third People's Hospital, Suining, People's Republic of China; 3 Ultrasonography Department, Suining Central Hospital, Suining, People's Republic of China; 4 AIER Ophthalmology, Suining, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xu Yang, Email Purpose: To study the expression and diagnostic ability of the long noncoding RNAs (lncRNAs) MIAT, HOTTIP, and SNHG16 in serum of patients with diabetic retinopathy. Methods: A total of 70 healthy controls and 195 patients with Type 2 Diabetes (T2D) were collected. T2D patients include 65 patients with Nondiabetic retinopathy (NDR), 65 patients with Nonproliferative diabetic retinopathy (NPDR) and 65 patients with Proliferative diabetic retinopathy (PDR). The relative expression of MIAT, HOTTIP and SNHG16 in participant serum was measured through Real-time fluorescence quantitative polymerase chain reaction to compare the differential expression between the groups. t test, Mann‒Whitney U -test, Pearson's chi-square test and the receiver operating characteristic (ROC) curve were used to analyze the expression of these LncRNAs and their diagnostic ability for DR. Results: We compare the healthy control group with T2D group, healthy control group with NDR group, NDR group with DR (NPDR+PDR) group, and NPDR group with PDR group. When NDR group was compared with the healthy control group, there was no difference between MIAT (p> 0.05)and HOTTIP (p> 0.05), only the relative expression of SNHG16(p< 0.05) was different and it's ROC curve had identification significance. In the remaining inter-group comparisons, the differences in the expression of MIAT (p< 0.05), HOTTIP (p< 0.05) and SNHG16 (p< 0.05) were statistically significant, and their ROC curves were all had identification significance. Conclusion: These findings prove that serum LncRNA MIAT, HOTTIP and SNHG16 may be used as potential markers to monitor the progress of DR. Keywords: LncRNA MIAT, HOTTIP, SNHG16, diabetic retinopathy, type 2 diabetes Diabetic retinopathy (DR) is the most common ocular complication of diabetic patients, and it is a series of fundus lesions caused by long-term retinal microvascular and nerve dysfunction. The global prevalence rate is about 35%, and the low vision or even blindness it causes has a serious impact on the quality of life of patients. 1,2 Nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) are two main clinical forms. Effective treatment of DR must be achieved through early diagnosis, and early treatment can prevent serious vision loss or even blindness. 3 In recent years, with the extensive application of sequencing technology in retina research, it has been proven that noncoding RNA is closely related to the occurrence and development of DR. 4 Whether these noncoding RNAs can be used as auxiliary diagnostic factors for DR and whether they can be used as potential therapeutic targets deserves our investigation. Long noncoding RNA (lncRNA) is a type of ncRNA with a transcript length of more than 200 nt that plays an important role in many vital activities, such as dose compensation, epigenetic regulation, cell cycle regulation and cell differentiation regulation. 5,6 LncRNAs have been confirmed to be widely involved in the regulation of retinal gene expression. 7 In the DR model, numerous lncRNAs showed abnormal expression. 8 These abnormally expressed lncRNAs may serve as potential biomarkers for the diagnosis and prognosis prediction of DR and become effective therapeutic targets. 5 At present, some studies have found that LncRNA OGRU, MALAT1, HOTAIR, etc. may be used as potential diagnostic markers of DR. 9 The serum levels of these LncRNAs were obviously different between normal population and DR population, but the researchers only compared the normal population and DR population, and did not make further comparison according to the classification of DR. Myocardial infarct-associated transcript (MIAT), an important heart-related lncRNA with a length of 30,051 bp, is located on chromosome 22q12.1, it involved in the biological processes of genome imprinting, chromatin modification and transcription activation. 10 Researchers have proven that serum MIAT expression in T2D patients is significantly higher than that in the healthy population. 11 -Abstract Truncated-
endocrinology & metabolism